GlassScriptPhysician profile
Mary C Ghere
NPI 1063679512
$4,030.27
in general payments reported to CMS, 2019-2025
12 companies · $645 in 2025
The $645 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.07 · 2020: $190 · 2021: $281 · 2022: $1,089 · 2023: $1,207 · 2024: $571 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,366 · Food and Beverage: $791 · Travel and Lodging: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,366.00 |
| Food and Beverage | $790.93 |
| Travel and Lodging | $266.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,697.20 | 2023-2024 | |
| Allergan, INC. | $877.83 | 2020-2022 | |
| Motiva USA, LLC | $619.60 | 2025 | |
| Sientra, INC. | $346.04 | 2021-2022 | |
| Galderma Laboratories, L.P. | $162.40 | 2020-2022 | |
| Depuy Synthes Sales INC. | $124.49 | 2022 | |
| Tela Bio, INC. | $61.06 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $43.05 | 2024-2025 | Exparel |
| Tepha INC | $34.26 | 2019 | |
| Smith+Nephew, INC. | $30.93 | 2024 | Stravix Pl, Stravix, Grafix Pl |
| Mentor Worldwide LLC | $20.60 | 2020 | |
| Merz North America, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ghere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.